Trial
NCT02992418
Study of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Adacel® in Healthy Subjects
Phase IIITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Sanofi Pasteur, a Sanofi Company
Collaborators
—
Condition
Dengue Fever
Intervention
CYD Dengue Vaccine
Why stopped
No answer received from the Philippines Food and Drug Administration on protocol amendment issued due to IDMC recommendations. CYD vaccine 3rd dose not given.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-03-25